CERTANIA Acquires Bioarray Genetic Diagnosis

July 9, 2025

CERTANIA, a Munich-based Testing, Inspection and Certification (TIC) group, has acquired Spanish genetic diagnostics lab Bioarray, which will join CERTANIA’s global network. Bioarray — headquartered in Elche (Alicante) — will continue to be led by cofounder Andrés Antón Salas and will leverage CERTANIA’s platform to expand its genomic diagnostics and research services internationally.

Buyers
CERTANIA Holding GmbH
Targets
Bioarray Genetic Diagnosis (Bioarray S.L.)
Location
Alicante, Spain
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.